Maryland PIRG Foundation
As the new home of Maryland PIRG’s environmental work, Environment Maryland can be contacted regarding this report.
Chlorinating tap water is a critical public health measure that saves thousands of lives each year by reducing the incidence of waterborne disease. But chlorination is no substitute for cleaning up America’s waters.
By failing to clean up rivers and reservoirs that provide drinking water for hundreds of millions of Americans, EPA and the Congress have forced water utilities to chlorinate water that is contaminated with animal waste, sewage, fertilizer, algae, and sediment, in order to provide water free of disease-causing microorganisms. Chlorine combined with the organic matter in this pollution produces harmful byproducts, collectively referred to as chlorination byproducts (CBPs). In spite of the diligent efforts of the water utilities to filter and clean the water before they chlorinate, CBP levels remain high in the water consumed by millions of people each day. Approximately 240 million Americans drink tap water contaminated with some level of CBPs.
A compelling body of scientific evidence – nearly 30 peer-reviewed epidemiologic studies – links chlorination byproducts to increased risks of cancer. At current levels in U.S. tap water, EPA estimates that CBPs cause up to 9,300 cases of bladder cancer each year. A growing body of science links CBPs to miscarriages and birth defects, including neural tube defects, low birth weight, and cleft palate. Other health problems from CBP exposure may include other cancers (rectal and colon), kidney and spleen disorders, immune system problems and neurotoxic effects (63 FR 69390- 69476).
Industrial water pollution is not a major contributor to CBPs in tap water. Instead the main causes are sediments, nutrients, and pollution from agricultural and urban runoff, and in some small systems, excess use of chlorine. Until Congress and the EPA act to limit pollution from farms and urban runoff so that water entering drinking water treatment plants is much cleaner than it is today, CBPs will remain at unacceptably high levels.
• A major national effort to clean up drinking water sources, focusing on reducing agricultural and urban pollutants that lead to chlorination byproducts.
• The creation of a nationwide health tracking network to help scientists and policymakers fully understand the link between tap water chlorination byproducts and specific birth defects, cancers, and miscarriage.
• Funding for programs to train operators of small town drinking water systems in improved chlorination techniques.
This first ever national analysis of chlorination byproducts in tap water from both large and small cities, conducted by the Environmental Working Group (EWG), shows that although most water suppliers are in compliance with current and future drinking water standards:
• More than 137,000 pregnancies each year are at increased risk of miscarriage and birth defects each year from exposure to CBPs in tap water.*
• Since 1995, more than 16 million people in 1,258 communities have been served water containing chlorination byproducts for 12 months in a row at levels above the legal limit going into effect in January 2002.*
• A handful of large cities with a history of high CBP levels account for a significant portion of the population at risk, including Washington, DC suburbs, Philadelphia, Pittsburgh suburbs, and San Francisco..
• The problem is not confined to large cities. More than 1,100 small towns (fewer than 10,000 people) have reported potentially dangerous levels of CBPs in their tap water over the past six years. Pregnant women living in small towns supplied by rivers and reservoirs are more than twice as likely to drink tap water with elevated levels of CBPs as women in larger communities. Historically, systems serving fewer than 10,000 people have been exempt from all federal health standards for CBPs.
Despite significant population-wide exposures to CBPs, a survey of federal and state-level efforts to monitor and track consumers’ exposure to CBPs and related health effects shows that the U.S. fails to collect essential tracking data at a national level that could provide key insight on causes and other critical information on miscarriages and birth defects linked to CBPs.
EWG and U.S. Public Interest Research Group’s (U.S. PIRG’s) compilation of survey information finds that 10 states and Washington, D.C., either have no birth defects surveillance system at all, or cursory systems that miss an estimated 90 percent of the cases. Not a single state has an active, wellfunded system in place to track first-trimester miscarriages, which account for 90 percent of all miscarriages and which also have been linked to CBP exposures.
The need for a nationwide health tracking network
In 1998, EPA completed a revision of the health standard governing two groups of chlorination byproducts in tap water. The new rule makes three major changes in policy. First, it eliminates the long standing exemption from health standards for systems serving less than 10,000 people; second, it lowers the amount of trihalomethanes (THMs, the most prevalent chlorination byproducts) allowed in tap water from 100 parts per billion on average over the course of a year, to 80 ppb; and third, it regulates haloacetic acids, another major class of chlorination byproducts, and two other byproducts called chlorite and bromate, for the first time.
The effectiveness of health standards for CBPs and other environmental contaminants is limited by the lack of reliable data on environmentally caused disease. In spite of the growing body of evidence linking CBPs to miscarriages, birth defects, and cancers, EPA lacked solid data on incidence rates for most of these effects, as well as exposure data to CBPs in tap water, throughout the standard setting process. The United States lacks a nationwide health tracking network that could provide reliable data on disease rates, pregnancy outcomes, and levels of exposure to environmental contaminants potentially responsible for harm.
Because of these data limitations, EPA formally considered the risks of just one cancer, bladder cancer, when setting the new health limits for CBPs. The agency made no estimate of the risk or potential reduction in the rates of other cancers, birth defects or miscarriages during the entire process (63 FR 69390-69476). The result is most likely an underestimate of the actual risk, and new health standards that may not significantly reduce the incidence of adverse health effects from CBPs.
EPA’s ability to quantify just one of the many health effects linked to CBP exposures (bladder cancer), illustrates how our country’s patchwork of health tracking programs ultimately hamstrings public health officials, forcing decisions that more often than not are based on just a fraction of the public health impacts from environmental contaminants. Tracking disease is a cornerstone of public health protection, and has been used effectively to identify and stop infectious disease outbreaks for decades. Nationwide, the tools of tracking and monitoring have not been consistently applied to chronic disease; birth defects and other conditions ranging from Alzheimer’s Disease to asthma to miscarriage remain inadequately tracked in the U.S.